Nutrients and risk of prostate cancer

Nutrition and Cancer

Volumn 62, Issue 6, 2010, Pages 710-718

  Hu, Jinfu ^a   La Vecchia, Carlo ^b,c   Gibbons, Laurrie ^a   Negri, Eva ^b   Mery, Les ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; DISACCHARIDE; MONOSACCHARIDE; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SUCROSE; TRANS FATTY ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CARBOHYDRATE INTAKE; CHOLESTEROL INTAKE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIET; FAT INTAKE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUTRIENT; PROSTATE CANCER; PROTEIN INTAKE; SOCIAL STATUS;

ADULT; AGED; CHOLESTEROL, DIETARY; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS;

EID: 77954984650     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605953     Document Type: Article

References (81)

1. Curado MP, Edwards B, Shin HR, Storn H, Ferlay J, et al.. (eds.): CancerIncidence in Five Continents, Vol.IX. IARC Scientific Publications No. 160. Lyon, France: IARC, 2007.
2. Canadian Cancer Society, Public Health Agency of Canada, and Statistics Canada: Canadian Cancer Statistics. Toronto, Canada: Canadian Cancer Society. 2009.
3. Schmid HP, Engeler DS, Pummer K, and Schmitz-Drager BJ: Prevention of prostate cancer: more questions than data. Recent Results Cancer Res 174, 101-107, 2007.
4. Dagnelie PC, Schuurman AG, Goldbohm RA, and Van Den Brandt PA: Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 93, 1139-1150, 2004.
5. Fleshner N and Zlotta AR: Prostate cancer prevention: past, present, and future. Cancer 11, 1889-1899, 2007.
6. Fleshner N, Bagnell PS, Klotz L, and Venkateswaran V: Dietary fat and prostate cancer. J Urol 171 (Pt 2), S19-S24, 2004.
7. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev 23, 72-81, 2001.
8. World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR, 2007.
9. Colli JL and Colli A: International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urol Oncol 24, 184-194, 2006.
10. Rohan TE, Howe GR, Burch JD, and Jain M: Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control 6, 145-154, 1995.
11. Lee MM, Wang RT, Hsing AW, Gu FL, Wang T, et al.: Case-control study of diet and prostate cancer in China. Cancer Causes Control 9, 545-552, 1998.
12. Bidoli E, Talamini R, Bosetti C, Negri E, Maruzzi D, et al.: Macronutrients, fatty acids, cholesterol, and prostate cancer risk. Ann Oncol 16, 152-157, 2005.
13. West DW, Slattery ML, RobisonLM, French TK, and Mahoney AW: Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2, 85-94, 1991.
14. Kristal AR, Cohen JH, Qu P, and Stanford JL: Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11, 719-725. 2002.
15. Godley PA, Campbell MK, Gallagher P, Martinson FE, Mohler JL, et al.: Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 5, 889-895, 1996.
16. De Stefani E, Deneo-Pellegrini H, Boffetta P, Ronco A, and Mendilaharsu M: Alpha-linolenic acid and risk of prostate cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 9, 335-338, 2000. (Pubitemid 30165448)
17. Key TJ, Silcocks PB, Davey GK, Appleby PN, and Bishop DT: A case- control study of diet and prostate cancer. Br J Cancer 76, 678-687, 1997.
18. McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, et al.: Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53, 33-41, 2005.
19. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS, et al.: Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev 17, 930-937, 2008.
20. Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King I, et al.: (n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers. J Nutr 137, 1821-1827, 2007.
21. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, et al.: Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86, 281-286, 1994.
22. Chavarro JE, Stampfer MJ, Campos H, Kurth T, Willett WC, et al.: Prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 17, 95-101, 2008.
23. King IB, Kristal AR, Schaffer S, Thornquist M, and Goodman GE: Serum trans-fatty acids are associated with risk of prostate cancer in beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 14, 988-992, 2005.
24. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, et al.: A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85, 1571-1579, 1993. (Pubitemid 23304685)
25. Veierød MB, Laake P, and Thelle DS: Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men. Int J Cancer 73, 634-638, 1997. (Pubitemid 127483056)
26. Severson RK, Nomura AM, Grove JS, and Stemmermann GN: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49, 1857-1860, 1989.
27. Schuurman AG, Van Den Brandt PA, Dorant E, Brants HA, and Goldbohm RA: Association of energy and fat intake with prostate carcinoma risk: results from the Netherlands Cohort Study. Cancer 86, 1019-1027, 1999.
28. Crowe FL, Key TJ, Appleby PN, Travis RC, Overvad K, et al.: Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 87, 1405-1413, 2008. (Pubitemid 351679784)
29. WallstromP, Bjartell A, Gullberg B, Olsson H, and Wirfält E: A prospective study on dietary fat and incidence of prostate cancer (Malmö, Sweden). Cancer Causes Control 18, 1107-11021, 2007.
30. Koralek DO, Peters U, Andriole G, Reding D, Kirsh V, et al.: A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States). Cancer Causes Control 17, 783-791, 2006.
31. Park SY, Murphy SP, Wilkens LR, Henderson BE, and Kolonel LN: Fat and meat intake and prostate cancer risk: the multiethnic cohort study. Int J Cancer 121, 1339-1345, 2007.
32. Iso H, Ikeda A, Inoue M, Sato S, Tsugane S, et al.: Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. Int J Cancer 125, 2679-2686, 2009.
33. Knekt P, Reunanen A, Aromaa A, Heliovaara M, Hakulinen T, et al.: Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol 41, 519-530, 1988.
34. Hiatt RA and Fireman BH: Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis 39, 861-870, 1986.
35. Lewis JE, Soler-Vila H, Clark PE, Kresty LA, Allen GO, et al.: Intake of plant foods and associated nutrients in prostate cancer risk. Nutr Cancer 61, 216-224, 2009.
36. Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, et al.: Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 98, 1574-1581, 2008.
37. Bakker N, Van't Veer P, and Zock PL: Adipose fatty acids and cancers of the breast, prostate and colon: an ecological study: EURAMIC Study Group. Int J Cancer 72, 587-591, 1997.
38. Augustin LS, Galeone C, Dal Maso L, Pelucchi C, Ramazzotti V, et al.: Glycemic index, glycemic load, and risk of prostate cancer. Int J Cancer 112, 446-450, 2004. (Pubitemid 39390609)
39. Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J, et al.: Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 11, 859-867, 2000.
40. Johnson KC, Mao Y, Argo J, Dubois S, Semenciw R, et al.: The National Enhanced Cancer Surveillance System: a case-control approach to environmental-related cancer surveillance in Canada. Environmetrics 9, 495-504, 1998.
41. Percy C, Holten VV, and Muir C: International Classification of Diseases for Oncology, 2nd ed. Geneva, Switzerland: World Health Organization, 1990.
42. World Health Organization: Obesity: preventing and managing the global epidemic. World Health Organization Technical Report Series, No.894. Report of a WHO consultation. Geneva, Switzerland: World Health Organization, 2000.
43. Block G, Hartman AM, and Naughton D: A reduced dietary questionnaire: development and validation. Epidemiology 1, 58-64, 1990.
44. Willett WC: Nutritional Epidemiology, 2nd ed. New York: Oxford University Press, 1998.
45. Health Canada: Canadian Nutrient File Compilation of Canadian Food Composition Data: Users' Guide. Ottawa, Canada: Nutrition Research Division and Office of Information Management Technology Health Products and Food Branch, Health Canada, 2005.
46. SAS Institute, Inc.: The SAS System for Windows Release 9.01. Cary, NC: SAS Institute, Inc., 2002.
47. Liu X, Schumacher FR, Plummer SJ, Jorgenson E, Casey G, et al.: Trans- fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant. Carcinogenesis 28, 1232-1236, 2007.
48. Hodge AM, English DR, McCredie MR, Severi G, Boyle P, et al.: Foods, nutrients, and prostate cancer. Cancer Causes Control 15, 11-20, 2004.
49. Nelson WG, De Marzo AM, DeWeese TL, and Isaacs WB: The role of inflammation in the pathogenesis of prostate cancer. J Urol 172(Pt 2), S6-S11, S11-S12, 2004.
50. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, et al.: Inflammation in prostate carcinogenesis. Nat Rev Cancer 7, 256-269, 2007.
51. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, et al.: Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 79, 606-612, 2004. (Pubitemid 41103904)
52. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, et al.: Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135, 562-566, 2005.
53. Dennis LK, Snetselaar LG, Smith BJ, Stewart RE, and Robbins ME: Problems with the assessment of dietary fat in prostate cancer studies. Am J Epidemiol 160, 436-444, 2004.
54. Thissen JP, Ketelslegers JM, and Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocr Rev 15, 80-101, 1994.
55. Platz EA, Clinton SK, and Giovannucci E: Association between plasma cholesterol and prostate cancer in the PSA era. Int J Cancer 123,1693-1698, 2008.
56. Jacobs EJ, Rodriguez C, Bain EB, Wang Y, Thun MJ, et al.: Cholesterol- lowering drugs and advanced prostate cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 16, 2213-2217, 2007.
57. Flick ED, Habel LA, Chan KA, Van Den Eeden SK, Quinn VP, et al.: Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev 16, 2218-2225, 2007.
58. Murtola TJ, Tammela TL, Lahtela J, and Auvinen A: Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 16, 2226-2232, 2007. (Pubitemid 351196353)
59. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, and Stanford JL: Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 168, 250-260, 2008.
60. Boudreau DM, Yu O, Buist DS, and Miglioretti DL: Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control 19, 767-774, 2008.
61. Taylor ML, Wells BJ, and Smolak MJ: Statins and cancer: a meta-analysis of case-control studies. Eur J Cancer Prev 17, 259-268, 2008.
62. Bonovas S, Filioussi K, and Sitaras NM: Statin use and the risk of prostate cancer: a meta-analysis of 6 randomized clinical trials and 13 observational studies. Int J Cancer 123, 899-904, 2008.
63. Hamilton RJ and Freedland SJ: Review of recent evidence in support of a role for statins in the prevention of prostate cancer. Curr Opin Urol 18, 333-339, 2008.
64. Moon HK, Kim CY, and Lee SW: Exploratory correlations of dietary nutrients with prostate cancer mortality using over two decades of observations in Korea. Mol Nutr Food Res 53, 185-190, 2009.
65. Smit E, Garcia-Palmieri MR, Figueroa NR, McGee DL, Messina M, et al.: Protein and legume intake and prostate cancer mortality in Puerto Rican men. Nutr Cancer 58, 146-152, 2007.
66. Schuurman AG, Van Den Brandt PA, Dorant E, and Goldbohm RA: Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study. Br J Cancer 80, 1107-1113, 1999.
67. Yan L and Spitznagel EL: Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89, 1155-1163, 2009.
68. Norat T, Dossus L, Rinaldi S, Overvad K, Grønbaek H, et al.: Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 61, 91-98, 2007.
69. Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, et al. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 16, 1121-1127, 2007.
70. Goetzl MA, Van Veldhuizen PJ, and Thrasher JB: Effects of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis 10, 216-223, 2007.
71. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, et al.: Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129, 1628-1635, 1999.
72. Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, et al.: Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 93, 783-789, 2001.
73. Tulinius H, Sigfiisson N, Sigvaldason H, Bjarnadottir K, and Tryggvadottir L: Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6, 863-873, 1997.
74. Hubbard JS, Rohrmann S, Landis PK, Metter EJ, Muller DC, et al.: Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology 63, 253-258, 2004.
75. George SM, Mayne ST, Leitzmann MF, Park Y, Schatzkin A, et al.: Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 169, 462-472, 2009.
76. Mavropoulos JC, Isaacs WB, Pizzo SV, and Freedland SJ: Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? Urology 68, 15-18, 2006.
77. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, et al.: Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363, 1346-1353, 2004.
78. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, et al.: Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Annals Internal Med 149, 461-471, 2008.
79. MacInnis RJ and English DR: Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17, 989-1003, 2006.
80. Copeland KT, Checkoway H, McMichale AJ, and Holbrook RH: Bias due to misclassification in the estimate of relative risk. Am J Epidemiol 105, 488-495, 1977.
81. D'Avanzo B, La Vecchia C, Katsouyanni K, Negri E, and Trichopoulos D: An assessment and reproducibility of food frequency data provided by hospital controls. Eur J Cancer Prev 6, 288-293, 1997.